PROS 2026 Education Day

PROS 2026 Education Day

Posted by PROS Secretariat | September 07, 2026 - 21:58

Meeting & Venue Details

• Date: Monday, September 14, 2026
• Time: 9:00 AM – 5:30 PM CDT
• In-Person Location:
  Mays Cancer Center
  4th Floor, Mabee Conference Room
  7979 Wurzbach Road, San Antonio, TX
  (Note: In-person seating capacity is limited to 45 attendees; lunch will be hosted across the skybridge at UT Health Multispecialty and Research Hospital.)
• Virtual Option: Live broadcast via Microsoft Teams and on-demand recorded access.

 

Agenda

Morning Sessions

• 09:00 AM – 10:45 AM | Resident Case-Based Presentations
  Featured Cases: Neuroblastoma, Wilms Tumor, ATRT, and NGGCT.
• 11:00 AM – 11:45 AM | Beyond Histology: Newly Defined Molecular and Methylation Tumor Entities
  Speaker: Maria A. Gubbiotti, MD, PhD (UT MD Anderson Cancer Center)
  Focus: Evolution of the WHO classification, challenges of implementing molecular diagnostics (methylation profiling, NGS) in resource-limited settings, and emerging entities such as HPAP, PLAG1-altered neuroepithelial tumors, and gliomatosis cerebri-like lesions.
• 12:00 PM – 01:00 PM | Lunch Break (UT Health Multispecialty and Research Hospital)

 

Afternoon Sessions

• 01:00 PM – 01:45 PM | Beyond Histology: Newly Defined Molecular and Methylation Tumor Entities (Part II)
  Speaker: Andrea Gilbert, DO (UT Health San Antonio)
• 02:00 PM – 02:45 PM | Rare Pediatric Malignancies: An Overview of Active Clinical Trials and Therapeutic Innovations
  Speaker: Kenneth S. Chen, MD (UT Southwestern / Children's Medical Center Dallas)
  Focus: Emerging clinical trials and the molecular/genetic drivers of rare pediatric solid tumors.
• 03:00 PM – 03:45 PM | Tried, True, and New in DIPG: Revisiting Hypofractionation, Reirradiation, ONC201, and Emerging Cellular Therapies
  Speaker: Gohar S. Manzar, MD, PhD (UT MD Anderson Cancer Center)
  Focus: Radiobiology and clinical trials evaluating hypofractionated vs. conventional regimens, salvage reirradiation patient selection and safety, the ACTION trial/ONC201 therapeutics, and novel intracranial CAR-T cell platforms.
• 04:00 PM – 04:45 PM | Highlights Session: 2026 ISLCC Highlights
  Speaker: Rebecca M. Howell, PhD (UT MD Anderson Cancer Center)
  Focus: Workflow-integrated late-effects risk calculators, cardiac disease modeling/screening (COROCAN study), PanCareSurFup secondary malignancy data, and long-term survivorship management.
• 05:00 PM – 05:30 PM | SIOP San Antonio Scientific Program Highlights
  Speaker: Anita Mahajan, MD (Johns Hopkins Medicine)

 

Virtual On-Demand / Program Highlights

• ISPNO 2026 Highlights: Updates for the Pediatric Radiation Oncologist
  Speaker: Sahaja Acharya, MD (Johns Hopkins Medicine)
• Comparative Outcomes of Early Focal, CSI, and Omission Protocols for Infants with Embryonal Tumors: Practical Aspects for the Radiation Oncologist
  Speaker: Justin Oh, MD, FRCPC (BC Cancer / University of British Columbia)
  Focus: Salvage re-irradiation field matching, biological dose accumulation, and mitigating both acute and long-term toxicities.

 

Registration & Attendance Confirmation

Given the limited in-person capacity (45 seats) at the Mabee Conference Room, we encourage attendees intending to join in person to register early. Virtual attendance links and instructions will be circulated prior to the event date.

 

Please RSVP indicating whether you plan to attend in-person or virtually at the following link: https://bit.ly/3TgqXUK